Close Menu

NEW YORK – Exact Sciences reported after the close of the market on Tuesday that its fourth quarter revenues rose 58 percent year over year, in line with preliminary results announced last month. Revenues from cancer screening, the firm's largest business segment, increased 9 percent during the quarter.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.